Stuart Blackburn
Overview
Explore the profile of Stuart Blackburn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Strand V, Deodhar A, Alten R, Sullivan E, Blackburn S, Tian H, et al.
J Clin Rheumatol
. 2020 Aug;
27(8):e446-e455.
PMID: 32826654
Background/objective: Patients with ankylosing spondylitis (AS) experience symptoms and comorbidities that impact their health-related quality of life (HRQoL) and ability to work. This real-world, global survey was conducted among AS...
2.
Conaghan P, Alten R, Deodhar A, Sullivan E, Blackburn S, Tian H, et al.
RMD Open
. 2020 Jul;
6(2).
PMID: 32611650
Background/objective: The incidence of pain and/or fatigue in people with psoriatic arthritis (PsA) is associated with reduced health-related quality of life (HRQoL) and the ability to work, despite modern advanced...
3.
Sullivan E, Kershaw J, Blackburn S, Mahajan P, Boklage S
Rheumatol Ther
. 2020 May;
7(3):517-535.
PMID: 32440826
Introduction: Tumor necrosis factor inhibitors (TNFi) are commonly used as first-line therapy (biologic disease-modifying antirheumatic drug [bDMARD] and targeted synthetic DMARD [tsDMARD]: defined as targeted therapy) for patients with moderate-to-severe...
4.
Sullivan E, Kershaw J, Blackburn S, Choi J, Curtis J, Boklage S
Rheumatol Ther
. 2020 Apr;
7(2):383-400.
PMID: 32318979
Introduction: Some patients with rheumatoid arthritis (RA) using tumor necrosis factor inhibitors (TNFi) experience inefficacy or lack of tolerability and hence switch to another TNFi (cycling) or to a therapy...
5.
Peterson S, Piercy J, Blackburn S, Sullivan E, Karyekar C, Li N
BMC Rheumatol
. 2019 Nov;
3:43.
PMID: 31673680
Background: The prevalence of mood disturbances such as anxiety and depression is greater in rheumatoid arthritis (RA) patients than in the general population. Given this association, the primary aim of...
6.
Wei W, Sullivan E, Blackburn S, Chen C, Piercy J, Curtis J
BMC Rheumatol
. 2019 Jul;
3:25.
PMID: 31312786
Background: Heterogeneity in assessments of rheumatoid arthritis (RA) disease remission, based on physician judgment and patient self-reports versus standardized measures, have previously been reported. This study explored the prevalence and...
7.
Boegemann M, Hubbe M, Thomaidou D, Blackburn S, Bent-Ennakhil N, Wood R, et al.
Anticancer Res
. 2018 Nov;
38(11):6413-6422.
PMID: 30396966
Background/aim: Sunitinib is the current standard of care for first-line (1L) treatment of metastatic renal cell carcinoma (mRCC). Previous studies suggest that a modified treatment schedule may benefit patients. Our...
8.
Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, et al.
J Dermatol
. 2017 Nov;
45(2):150-157.
PMID: 29131384
Since control of atopic dermatitis (AD) remains challenging but has not been adequately characterized, the objective of this study was to characterize disease control among patients with a history of...
9.
Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, et al.
Am J Clin Dermatol
. 2017 Apr;
18(6):825-835.
PMID: 28447213
Background: There is limited understanding of severity rating of atopic dermatitis in clinical practice. Objectives: To evaluate the agreement between physician- and patient-rated severity of atopic dermatitis. Methods: Data were...